These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8973736)

  • 21. [Localized pemphigus].
    Kharfi M; Fazaa B; Benmously R; Bouden S; Elloumi L; Kamoun MR
    Ann Dermatol Venereol; 2003; 130(6-7):645-7. PubMed ID: 13679705
    [No Abstract]   [Full Text] [Related]  

  • 22. A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
    Taintor AR; Leiferman KM; Hashimoto T; Ishii N; Zone JJ; Hull CM
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S73-6. PubMed ID: 17434044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Follicular lymphoma with paraneoplastic autoimmune multiorgan syndrome].
    Hidalgo I; Martinez F; Grau C; Gil I; Azón A
    Actas Dermosifiliogr; 2012 Apr; 103(3):244-6. PubMed ID: 21943876
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and immunopathological spectrum of paraneoplastic pemphigus.
    Zimmermann J; Bahmer F; Rose C; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2010 Aug; 8(8):598-606. PubMed ID: 20180886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Paraneoplastic pemphigus and adenocarcinoma of the colon].
    Chamberland M
    Union Med Can; 1993; 122(3):201-3. PubMed ID: 8328113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraneoplastic pemphigus occurring in a patient with B-cell non-Hodgkin's lymphoma.
    Schlesinger T; McCarron K; Camisa C; Anhalt G
    Cutis; 1998 Feb; 61(2):94-6. PubMed ID: 9515216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.
    Verrini A; Cannata G; Cozzani E; Terracini M; Parodi A; Rebora A
    Acta Derm Venereol; 2002; 82(5):382-4. PubMed ID: 12430743
    [No Abstract]   [Full Text] [Related]  

  • 28. Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature.
    Lane JE; Woody C; Davis LS; Guill MF; Jerath RS
    Pediatrics; 2004 Oct; 114(4):e513-6. PubMed ID: 15466078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease.
    Nousari HC; Brodsky RA; Jones RJ; Grever MR; Anhalt GJ
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):750-4. PubMed ID: 10321604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome.
    Sehgal VN; Srivastava G
    Int J Dermatol; 2009 Feb; 48(2):162-9. PubMed ID: 19200194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraneoplastic pemphigus with negative direct immunofluorescence in epidermis or mucosa but positive findings in adnexal structures.
    Barnadas MA; Curell R; Alomar A; Gelpí C
    J Cutan Pathol; 2009 Jan; 36(1):34-8. PubMed ID: 18564282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cell adhesion molecules and extracellular matrix components as target structures of autoimmunity].
    Moll R; Bahn H; Bayerl C; Moll I
    Verh Dtsch Ges Pathol; 1996; 80():67-79. PubMed ID: 9065056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic pemphigus.
    Zhu X; Zhang B
    J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis.
    Frew JW; Murrell DF
    Dermatol Clin; 2011 Jul; 29(3):419-25, viii. PubMed ID: 21605807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus.
    Williams JV; Marks JG; Billingsley EM
    Br J Dermatol; 2000 Mar; 142(3):506-8. PubMed ID: 10735959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China.
    Wang J; Zhu X; Li R; Tu P; Wang R; Zhang L; Li T; Chen X; Wang A; Yang S; Wu Y; Yang H; Ji S
    Arch Dermatol; 2005 Oct; 141(10):1285-93. PubMed ID: 16230567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
    Heizmann M; Itin P; Wernli M; Borradori L; Bargetzi MJ
    Am J Hematol; 2001 Feb; 66(2):142-4. PubMed ID: 11421295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SnapshotDx Quiz: November 2017.
    Patel S; Miteva M
    J Invest Dermatol; 2017 Nov; 137(11):e193. PubMed ID: 29055416
    [No Abstract]   [Full Text] [Related]  

  • 39. Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
    Frew JW; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):607-12. PubMed ID: 21925005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
    Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.